The Coronavirus continues to spread, the Numbers of the Infected are changing rapidly. In the meantime, the pathogen has occurred in more than two dozen countries. Researchers are under pressure to vaccines and drugs. What we know at present about the Virus.
More than 43,000 people have been infected worldwide with the Coronavirus, also 2019-nCoV called, most (42.658) in China. These Figures shows a current graph of the Johns Hopkins University in Baltimore, USA. A little less of the cases, namely, 42.968, according to the WHO 11. February 10 at around the world.
1018 people died of the novel pathogen, almost all in China. More than four Times as many people (4228) have recovered completely from the Virus.
The Robert Koch Institute (RKI) describes the current situation as “very dynamic and rapidly developing and serious Situation”. Further, it means that the danger for Germany would continue to be assessed as low, it should be open, however, whether it will succeed in the global spread of the pathogen isolate.
The vast majority of the Coronavirus-Infected is currently in China. Risk areas were classified according to the RKI:
In addition to China in 2019 arrived-nCoV in more than two dozen other countries – the case of low numbers in these countries:
So far, Doctors and scientists have still time to develop a therapeutic drug, or to identify that the corona virus is attacking specifically. Although there are various known types of corona viruses such as the Sars Virus – however, these are very different, which is why it is hard to develop a drug, which helps against all these pathogens.
Currently doctors are already using well-known virus medicines in the fight against 2019-nCoV. Particularly promising in the EU for the treatment of Ebola approved drug seems to be Remdesivir.
Physician at China-Japan Friendship Hospital in Beijing already have begun two clinical trials. You want to treat two groups of patients: One includes patients with a mild or moderate course, and the other those with a severe pneumonia. You should receive Remdesivir or a Placebo. Until April, the results should be available.
More options in the therapy might be according to current information, the following are among the drugs being tested in clinical trials:
The infection to contain numbers, scientists are also currently on the development of vaccines, including two German locations. The biotech company CureVac in Tübingen, for example, developed a mRNA vaccine. Also at the German center for infection research (DZIF), researchers are working on a vaccine. There are at least a year to take, however, to be clear, whether he’s acting, and safe, estimates Stephan Becker, Director of the Institute for Virology at Philipps-University of Marburg and the DZIF.
In China, the vaccine development is also in different locations. Several institutions have been mandated according to state media in parallel by the government.
The hospital of the Tongji University in Shanghai, according to the Chinese news Agency Xinhua, together with the company Stermirna Therapeutics, such as the tübingen-based scientists to a new mRNA vaccine. The preparation of the samples would take, according to the company more than 40 days. They would then be sent for testing purposes and as soon as possible in the clinics brought.
Of vaccines, the centers for control and prevention of diseases of Zhejiang province and the capital, Beijing, to research, according to a report in the daily newspaper “China Daily” but. How quickly a vaccine could be developed, it is estimated by Chinese experts, but in different ways.
Currently, it is assumed that in 2019-comes nCoV of wild animals. The first Patients are expected to have a market in Wuhan at the end of December 2019 plugged in. As a possible Vector species of snakes or bats shifted to first in the point of view. The latest research results of biologists from the South China Agricultural University in Guangzhou suggest, however, a Pangolin as a Carrier.
The researchers compared the genome of corona virus from Pangolinen by 2019-nCoV, the samples of diseased patients came. In the process, they found a Match of 99 percent. This result, they argued the science journal “Nature” that a few days ago at a press conference, the data are not yet published in full.
The symptoms of the new respiratory disease resemble the flu. Typical first symptoms are:
Because the Virus infects the lower respiratory tract, have to be Concerned, but no runny nose.
The pathogen is apparently droplets of both over – and smear infection transfer. Whether 2019-may nCoV will also be disseminated through the digestive system, is not yet clarified.
Also the protection against the novel Coronavirus is similar to the case of a flu. Those who want to protect themselves and others, should pay attention to:
Also, children should be aware of the need to take better care of hand hygiene, to sneeze into the crook of one arm, or cough.
PCP “Alarming contamination cases”: WHO chief alerted to new infections